Pathological Response and Circulating Tumor Cell Count Identifies Treated HER2+ Inflammatory Breast Cancer Patients with Excellent Prognosis: BEVERLY-2 Survival Data
暂无分享,去创建一个
J. Bonneterre | M. Campone | T. Petit | F. Bidard | J. Pierga | P. Viens | T. Bachelot | E. Charafe-Jauffret | J. Gligorov | J. Ferrero | F. Lerebours | C. Lévy | H. Roché | Juana Hernandez